LSTA
LISATA THERAPEUTICS, INC.
Company overview
- Market capitalization
- $13.52M
- Employees
- 21
- Latest publication
- 2026-09-29
About LISATA THERAPEUTICS, INC.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 100,000USD | 0USD | 70,000USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 2,000USD | 15,000USD | — | 44,000USD | 43,000USD | 41,000USD | 45,000USD | 46,000USD |
| Gross Profit | -2,000USD | 100,000USD | — | 70,000USD | -43,000USD | -41,000USD | -45,000USD | -46,000USD |
| Research Development | 1,204,000USD | 1,134,000USD | 1,959,000USD | 2,253,000USD | 2,602,000USD | 2,542,000USD | 2,601,000USD | 3,241,000USD |
| Selling General Administrative | 3,738,000USD | 2,045,000USD | 2,455,000USD | 2,685,000USD | 3,245,000USD | 2,794,000USD | 2,922,000USD | 3,360,000USD |
| Total Operating Expenses | 4,940,000USD | 3,179,000USD | 4,414,000USD | 4,938,000USD | 5,847,000USD | 5,336,000USD | 5,523,000USD | 6,601,000USD |
| Operating Income | -4,942,000USD | -3,079,000USD | -4,414,000USD | -4,868,000USD | -5,847,000USD | -5,336,000USD | -5,523,000USD | -6,601,000USD |
| Income Before Tax | -4,876,000USD | -2,954,000USD | -4,249,000USD | -4,659,000USD | -5,686,000USD | -4,930,000USD | -5,044,000USD | -6,199,000USD |
| Income Tax Expense | -387,000USD | — | — | — | -962,000USD | — | — | -798,000USD |
| Tax Provision | -387,000USD | 0USD | 0USD | 0USD | -962,000USD | 0USD | 0USD | -798,000USD |
| Net Income | -4,489,000USD | -2,954,000USD | -4,249,000USD | -4,659,000USD | -4,724,000USD | -4,930,000USD | -5,044,000USD | -5,401,000USD |
| Net Income From Continuing Ops | -4,489,000USD | -2,954,000USD | -4,249,000USD | -4,659,000USD | -4,724,000USD | -4,930,000USD | -5,044,000USD | -5,401,000USD |
| Ebit | -4,876,000USD | -2,954,000USD | -4,249,000USD | -4,659,000USD | -5,686,000USD | -4,930,000USD | -5,044,000USD | -6,199,000USD |
| Ebitda | -4,874,000USD | -2,939,000USD | -4,205,000USD | -4,615,000USD | -5,643,000USD | -4,888,000USD | -4,999,000USD | -6,153,000USD |
| Depreciation And Amortization | 2,000USD | 15,000USD | 44,000USD | 44,000USD | 43,000USD | 42,000USD | 45,000USD | 46,000USD |
| Reconciled Depreciation | 2,000USD | 15,000USD | 44,000USD | 44,000USD | 43,000USD | 42,000USD | 45,000USD | 46,000USD |
| Total Other Income Expense Net | 66,000USD | 125,000USD | 165,000USD | 209,000USD | 161,000USD | 406,000USD | 479,000USD | 402,000USD |
| Minority Interest | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | 45,000USD | 46,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 170,000USD | 1,000,000USD | 0USD | 121,372,000USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 146,000USD | 174,000USD | 189,000USD | 69,000USD | 55,000USD | 63,000USD | 65,000USD | 225,000USD |
| Gross Profit | 24,000USD | 1,000,000USD | -189,000USD | 63,771,000USD | -55,000USD | -63,000USD | -65,000USD | -225,000USD |
| Research Development | 7,949,000USD | 11,334,000USD | 12,734,000USD | 43,460,000USD | 17,576,000USD | 9,253,000USD | 13,497,000USD | 7,594,000USD |
| Selling General Administrative | 10,430,000USD | 12,075,000USD | 12,974,000USD | 14,141,000USD | 11,474,000USD | 9,892,000USD | 9,295,000USD | 9,393,000USD |
| Total Operating Expenses | 18,233,000USD | 23,409,000USD | 25,708,000USD | 57,601,000USD | 29,050,000USD | 19,145,000USD | 20,092,000USD | 16,987,000USD |
| Operating Income | -18,209,000USD | -22,409,000USD | -25,708,000USD | -57,601,000USD | -29,050,000USD | -19,145,000USD | -20,092,000USD | -16,987,000USD |
| Income Before Tax | -17,548,000USD | -20,783,000USD | -23,170,000USD | -56,704,000USD | -28,974,000USD | -19,013,000USD | -19,352,000USD | -16,168,000USD |
| Income Tax Expense | -962,000USD | -798,000USD | -2,330,000USD | -2,479,000USD | -1,508,000USD | -10,872,000USD | 749,000USD | -1,000USD |
| Tax Provision | -962,000USD | -798,000USD | -2,330,000USD | -2,479,000USD | -1,508,000USD | -10,872,000USD | -10,872,000USD | 0USD |
| Net Income | -16,586,000USD | -19,985,000USD | -20,840,000USD | -54,225,000USD | -27,466,000USD | -8,150,000USD | -20,101,000USD | -16,167,000USD |
| Net Income From Continuing Ops | -16,586,000USD | -19,985,000USD | -20,840,000USD | -54,225,000USD | -27,466,000USD | -8,141,000USD | -19,352,000USD | -16,168,000USD |
| Ebit | -17,548,000USD | -20,783,000USD | -23,170,000USD | -56,704,000USD | -28,974,000USD | -19,145,000USD | -20,092,000USD | -16,987,000USD |
| Ebitda | -17,402,000USD | -20,609,000USD | -22,981,000USD | -56,635,000USD | -28,919,000USD | -19,082,000USD | -20,027,000USD | -16,762,000USD |
| Depreciation And Amortization | 146,000USD | 174,000USD | 189,000USD | 69,000USD | 55,000USD | 63,000USD | 65,000USD | 225,000USD |
| Reconciled Depreciation | 146,000USD | 174,000USD | 189,000USD | 69,000USD | 55,000USD | 63,000USD | 65,000USD | 225,000USD |
| Total Other Income Expense Net | 661,000USD | 1,626,000USD | 2,538,000USD | 897,000USD | 76,000USD | 132,000USD | 740,000USD | 819,000USD |
| Minority Interest | 0USD | 0USD | 0USD | 0USD | 1,000USD | -9,000USD | -9,000USD | 1,000USD |
| Interest Expense | — | — | — | 1,949,000USD | 227,000USD | 123,000USD | 0USD | 5,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | -27,466,000USD | -8,150,000USD | -19,361,000USD | -16,167,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | -2,700,000USD | — |
| Net Interest Income | — | — | — | — | — | — | 0USD | -5,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 14,059,000USD | 17,744,000USD | 21,759,000USD | 25,160,000USD | 28,981,000USD | 35,002,000USD | 38,199,000USD | 42,571,000USD |
| Other Current Assets | 960,000USD | 1,047,000USD | 1,375,000USD | 2,414,000USD | 2,034,000USD | 2,433,000USD | 1,836,000USD | 3,716,000USD |
| Total Liab | 3,387,000USD | 3,143,000USD | 4,640,000USD | 4,385,000USD | 3,879,000USD | 5,685,000USD | 4,763,000USD | 4,576,000USD |
| Total Stockholder Equity | 10,926,000USD | 14,855,000USD | 17,373,000USD | 21,029,000USD | 25,356,000USD | 29,571,000USD | 33,690,000USD | 38,249,000USD |
| Other Current Liab | 2,805,000USD | 2,052,001USD | 3,949,000USD | 3,484,000USD | 3,113,000USD | 4,192,000USD | 3,954,000USD | 3,553,000USD |
| Common Stock | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 8,000USD | 8,000USD | 8,000USD |
| Capital Stock | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 8,000USD | 8,000USD | 8,000USD |
| Retained Earnings | -569,141,000USD | -564,652,000USD | -561,698,000USD | -557,449,000USD | -552,790,000USD | -548,066,000USD | -543,456,000USD | -538,526,000USD |
| Cash | 13,060,000USD | 15,956,000USD | 18,998,000USD | 16,835,000USD | 20,217,000USD | 16,209,000USD | 19,509,000USD | 28,293,000USD |
| Cash And Short Term Investments | 13,060,000USD | 15,956,000USD | 18,998,000USD | 21,970,000USD | 25,833,000USD | 31,245,000USD | 35,856,000USD | 38,262,000USD |
| Total Current Assets | 14,020,000USD | 17,703,000USD | 21,575,000USD | 24,885,000USD | 28,617,000USD | 34,578,000USD | 37,692,000USD | 41,978,000USD |
| Total Current Liabilities | 3,315,000USD | 3,071,000USD | 4,568,000USD | 4,313,000USD | 3,807,000USD | 5,613,000USD | 4,691,000USD | 4,457,000USD |
| Net Debt | -13,060,000USD | -15,956,000USD | -18,998,000USD | -16,788,000USD | -20,125,000USD | -16,072,000USD | -19,328,000USD | -28,117,000USD |
| Accounts Payable | 510,000USD | 1,018,999USD | 619,000USD | 782,000USD | 602,000USD | 1,284,000USD | 556,000USD | 728,000USD |
| Property Plant Equipment Net | 16,000USD | 18,000USD | 22,000USD | 48,000USD | 74,000USD | 72,000USD | 96,000USD | 119,000USD |
| Property Plant Equipment Gross | 494,000USD | 494,000USD | 494,000USD | 566,000USD | 689,000USD | 661,000USD | 661,000USD | 661,000USD |
| Accumulated Other Comprehensive Income | -21,000USD | -37,000USD | -42,000USD | -50,000USD | -78,000USD | -81,000USD | -32,000USD | -77,000USD |
| Common Stock Shares Outstanding | 9,006,000shares | 8,687,000shares | 8,738,000shares | 8,605,000shares | 8,602,000shares | 8,329,000shares | 8,321,000shares | 8,308,000shares |
| Non Current Assets Total | 39,000USD | 41,000USD | 184,000USD | 275,000USD | 364,000USD | 424,000USD | 507,000USD | 593,000USD |
| Non Current Liabilities Total | 72,000USD | 72,000USD | 72,000USD | 72,000USD | 72,000USD | 72,000USD | 72,000USD | 119,000USD |
| Non Current Liabilities Other | 72,000USD | 72,000USD | 72,000USD | 72,000USD | 72,000USD | 72,000USD | 72,000USD | 119,000USD |
| Non Currrent Assets Other | 23,000USD | 23,000USD | 23,000USD | 70,000USD | 116,000USD | 160,000USD | 201,000USD | 246,000USD |
| Net Working Capital | 10,705,000USD | 14,632,000USD | 17,007,000USD | 20,572,000USD | 24,810,000USD | 28,965,000USD | 33,001,000USD | 37,521,000USD |
| Unclassified Equity | 580,070,000USD | 579,526,000USD | 579,095,000USD | 578,510,000USD | 578,206,000USD | 577,702,000USD | 577,162,000USD | 576,836,000USD |
| Short Term Investments | — | 0USD | 0USD | 5,135,000USD | 5,616,000USD | 15,036,000USD | 16,347,000USD | 9,969,000USD |
| Net Receivables | — | 700,000USD | 1,202,000USD | 501,000USD | 750,000USD | 900,000USD | 200,000USD | 1,000,000USD |
| Intangible Assets | — | — | 139,000USD | 157,000USD | 174,000USD | 192,000USD | 210,000USD | 228,000USD |
| Short Term Debt | — | — | — | 47,000USD | 92,000USD | 137,000USD | 181,000USD | 176,000USD |
| Short Long Term Debt Total | — | — | — | 47,000USD | 92,000USD | 137,000USD | 181,000USD | 176,000USD |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -728,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 17,744,000USD | 35,002,000USD | 54,694,000USD | 73,034,000USD | 97,008,000USD | 36,002,000USD | 27,153,000USD | 44,580,000USD |
| Other Current Assets | 1,047,000USD | 2,433,000USD | 3,389,000USD | 2,650,000USD | 1,212,000USD | 758,000USD | 815,000USD | 1,053,000USD |
| Total Liab | 3,143,000USD | 5,685,000USD | 6,800,000USD | 6,710,000USD | 5,008,000USD | 3,760,000USD | 6,600,000USD | 7,126,000USD |
| Total Stockholder Equity | 14,855,000USD | 29,571,000USD | 48,148,000USD | 66,578,000USD | 92,254,000USD | 32,496,000USD | 20,816,000USD | 37,726,000USD |
| Other Current Liab | 2,052,001USD | 4,192,000USD | 4,001,000USD | 3,548,000USD | 2,360,000USD | 2,116,000USD | 4,132,000USD | 4,857,000USD |
| Common Stock | 9,000USD | 8,000USD | 8,000USD | 8,000USD | 4,000USD | 19,000USD | 11,000USD | 10,000USD |
| Capital Stock | 9,000USD | 8,000USD | 8,000USD | 8,000USD | 60,000USD | 19,000USD | 11,000USD | 10,000USD |
| Retained Earnings | -564,652,000USD | -548,066,000USD | -528,081,000USD | -507,241,000USD | -453,016,000USD | -425,550,000USD | -417,400,000USD | -397,977,000USD |
| Cash | 15,956,000USD | 16,209,000USD | 22,593,000USD | 32,154,000USD | 24,647,000USD | 16,512,000USD | 14,032,000USD | 10,299,000USD |
| Cash And Short Term Investments | 15,956,000USD | 31,245,000USD | 50,535,000USD | 69,226,000USD | 94,970,000USD | 34,573,000USD | 25,157,000USD | 43,053,000USD |
| Total Current Assets | 17,703,000USD | 34,578,000USD | 53,924,000USD | 71,876,000USD | 96,182,000USD | 35,331,000USD | 25,972,000USD | 44,106,000USD |
| Total Current Liabilities | 3,071,000USD | 5,613,000USD | 6,590,000USD | 6,383,000USD | 4,523,000USD | 3,506,000USD | 5,976,000USD | 5,619,000USD |
| Net Debt | -15,956,000USD | -16,072,000USD | -22,425,000USD | -31,669,000USD | -23,933,000USD | -15,888,000USD | -13,054,000USD | -10,299,000USD |
| Short Term Investments | 0USD | 15,036,000USD | 27,942,000USD | 37,072,000USD | 70,323,000USD | 18,061,000USD | 11,125,000USD | 32,754,000USD |
| Net Receivables | 700,000USD | 900,000USD | 1,000,000USD | — | — | — | — | — |
| Accounts Payable | 1,018,999USD | 1,284,000USD | 2,421,000USD | 2,655,000USD | 1,934,000USD | 1,020,000USD | 1,490,000USD | 762,000USD |
| Property Plant Equipment Net | 18,000USD | 72,000USD | 175,000USD | 296,000USD | 62,000USD | 57,000USD | 100,000USD | 165,000USD |
| Property Plant Equipment Gross | 494,000USD | 661,000USD | 661,000USD | 713,000USD | 430,000USD | 370,000USD | 349,000USD | — |
| Accumulated Other Comprehensive Income | -37,000USD | -81,000USD | -42,000USD | -29,000USD | -70,000USD | -13,000USD | 2,000USD | -32,000USD |
| Common Stock Shares Outstanding | 8,687,000shares | 8,329,000shares | 8,073,000shares | 5,180,000shares | 3,688,000shares | 1,029,000shares | 688,333shares | 645,933shares |
| Non Current Assets Total | 41,000USD | 424,000USD | 770,000USD | 1,158,000USD | 826,000USD | 671,000USD | 1,181,000USD | 474,000USD |
| Non Current Liabilities Total | 72,000USD | 72,000USD | 210,000USD | 327,000USD | 485,000USD | 254,000USD | 624,000USD | 1,507,000USD |
| Non Current Liabilities Other | 72,000USD | 72,000USD | 210,000USD | 22,000USD | — | — | 624,000USD | 1,507,000USD |
| Non Currrent Assets Other | 23,000USD | 160,000USD | 332,000USD | 528,000USD | 764,000USD | 614,000USD | 1,081,000USD | 309,000USD |
| Net Working Capital | 14,632,000USD | 28,965,000USD | 47,334,000USD | 65,493,000USD | 91,659,000USD | 31,825,000USD | 19,996,000USD | 38,487,000USD |
| Unclassified Equity | 579,526,000USD | 577,702,000USD | 576,255,000USD | 573,832,000USD | 545,276,000USD | 458,021,000USD | 438,192,000USD | 435,715,000USD |
| Intangible Assets | — | 192,000USD | 263,000USD | 334,000USD | — | — | — | — |
| Short Term Debt | — | 137,000USD | 168,000USD | 180,000USD | 229,000USD | 370,000USD | 354,000USD | — |
| Short Long Term Debt Total | — | 137,000USD | 168,000USD | 485,000USD | 714,000USD | 624,000USD | 978,000USD | — |
| Other Assets | — | — | — | — | 1,212,000USD | 40,000USD | 0USD | 309,000USD |
| Net Tangible Assets | — | — | — | — | 92,254,000USD | 32,496,000USD | 20,816,000USD | 37,726,000USD |
| Unclassified Non Current Assets | — | — | — | — | -1,212,000USD | — | — | — |
| Other Liab | — | — | — | — | — | — | 624,000USD | 1,507,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | 2,532,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | — | -2,532,000USD | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | — | -1,507,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,489,000USD | -2,954,000USD | -4,249,000USD | -4,659,000USD | -4,724,000USD | -4,610,000USD | -4,930,000USD | -5,044,000USD |
| Depreciation | 2,000USD | 15,000USD | 44,000USD | 44,000USD | 43,000USD | 41,000USD | 42,000USD | 45,000USD |
| Stock Based Compensation | 364,000USD | 225,000USD | 232,000USD | 239,000USD | 530,000USD | 871,763USD | 327,000USD | 237USD |
| Other Non Cash Items | 364,000USD | 627,000USD | -14,000USD | -20,000USD | -41,000USD | -1,188,763USD | -61,000USD | 103,763USD |
| Change To Account Receivables | 0USD | 3,000USD | -1,000USD | 249,000USD | 150,000USD | -900,000USD | 0USD | 0USD |
| Change In Working Capital | 1,040,000USD | -1,162,000USD | 645,000USD | 440,000USD | -1,210,000USD | 358,000USD | 2,104,000USD | -388,000USD |
| Total Cash From Operating Activities | -3,083,000USD | -3,249,000USD | -3,342,000USD | -3,956,000USD | -5,402,000USD | -4,528,000USD | -2,518,000USD | -5,283,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -28,000USD | -28,000USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -3,083,000USD | -3,249,000USD | -3,342,000USD | -3,984,000USD | -5,430,000USD | -4,528,000USD | -2,518,000USD | -5,283,000USD |
| Investments | 0USD | 0USD | 5,150,000USD | 505,000USD | 9,431,000USD | 1,389,000USD | -6,305,000USD | 11,713,000USD |
| Total Cash From Financing Activities | 181,000USD | 205,000USD | 353,000USD | 64,000USD | -23,000USD | -96,000USD | 0USD | 32,000USD |
| Issuance Of Capital Stock | 0USD | 205,000USD | 353,000USD | 74,000USD | 212,000USD | 36,000USD | 0USD | 32,000USD |
| Change In Cash | -2,896,000USD | -3,042,000USD | 2,163,000USD | -3,382,000USD | 4,008,000USD | -3,300,000USD | -8,784,000USD | 6,488,000USD |
| Begin Period Cash Flow | 15,956,000USD | 18,998,000USD | 16,835,000USD | 20,217,000USD | 16,209,000USD | 19,509,000USD | 28,293,000USD | 21,805,000USD |
| End Period Cash Flow | 13,060,000USD | 15,956,000USD | 18,998,000USD | 16,835,000USD | 20,217,000USD | 16,209,000USD | 19,509,000USD | 28,293,000USD |
| Other Cashflows From Financing Activities | -159,000USD | 205,000USD | 353,000USD | -10,000USD | -235,000USD | -132,000USD | -32,000USD | 32,000USD |
| Total Cashflows From Investing Activities | — | — | 5,150,000USD | 505,000USD | 9,431,000USD | 1,389,000USD | -6,305,000USD | 11,713,000USD |
| Other Cashflows From Investing Activities | — | — | — | 28,000USD | 28,000USD | -130,000USD | -100,000USD | 100,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 142USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -16,586,000USD | -19,985,000USD | -20,840,000USD | -54,225,000USD | -27,466,000USD | -8,141,000USD | -19,352,000USD | -16,168,000USD |
| Depreciation | 146,000USD | 174,000USD | 189,000USD | 69,000USD | 55,000USD | 63,000USD | 65,000USD | 225,000USD |
| Stock Based Compensation | 1,226,000USD | 1,653,000USD | 2,038,000USD | 2,636,000USD | 2,005,000USD | 1,265,000USD | 1,295,000USD | 2,453,000USD |
| Other Non Cash Items | 552,000USD | -325,000USD | -957,000USD | 31,181,000USD | 2,514,000USD | 307,000USD | 232,000USD | -1,147,000USD |
| Change To Account Receivables | 401,000USD | -900,000USD | 0USD | — | — | — | — | — |
| Change In Working Capital | -1,287,000USD | -873,000USD | -462,000USD | -831,000USD | 647,000USD | -2,317,000USD | -1,122,000USD | -5,349,000USD |
| Total Cash From Operating Activities | -15,949,000USD | -19,356,000USD | -20,032,000USD | -21,170,000USD | -22,245,000USD | -8,823,000USD | -18,882,000USD | -19,986,000USD |
| Capital Expenditures | -28,000USD | 0USD | 0USD | -285,000USD | -60,000USD | -20,000USD | -20,000USD | -134,000USD |
| Free Cash Flow | -15,977,000USD | -19,356,000USD | -20,032,000USD | -21,455,000USD | -22,305,000USD | -8,843,000USD | -18,882,000USD | -20,120,000USD |
| Investments | 15,114,000USD | 13,233,000USD | 10,102,000USD | 28,911,000USD | -54,836,000USD | -7,257,000USD | 21,432,000USD | -7,123,000USD |
| Total Cashflows From Investing Activities | 15,086,000USD | 13,233,000USD | 10,102,000USD | 28,911,000USD | -54,896,000USD | -7,277,000USD | 21,432,000USD | -4,707,000USD |
| Total Cash From Financing Activities | 599,000USD | -206,000USD | 385,000USD | -224,000USD | 85,276,000USD | 18,580,000USD | 1,183,000USD | 824,000USD |
| Issuance Of Capital Stock | 844,000USD | 68,000USD | 321,000USD | 43,000USD | 85,500,000USD | 18,728,000USD | 1,313,000USD | 1,031,000USD |
| Change In Cash | -253,000USD | -6,384,000USD | -9,561,000USD | 7,507,000USD | 8,135,000USD | 2,480,000USD | 3,733,000USD | -23,869,000USD |
| Begin Period Cash Flow | 16,209,000USD | 22,593,000USD | 32,154,000USD | 24,647,000USD | 16,512,000USD | 14,032,000USD | 10,299,000USD | 34,168,000USD |
| End Period Cash Flow | 15,956,000USD | 16,209,000USD | 22,593,000USD | 32,154,000USD | 24,647,000USD | 16,512,000USD | 14,032,000USD | 10,299,000USD |
| Other Cashflows From Financing Activities | -253,000USD | -274,000USD | 64,000USD | -267,000USD | -224,000USD | -148,000USD | -130,000USD | -48,000USD |
| Other Cashflows From Investing Activities | — | -130,000USD | — | -3,320,000USD | -54,836USD | -7,257USD | 21,432USD | 2,550,000USD |
| Sale Purchase Of Stock | — | — | -91USD | -267USD | -248USD | -148USD | -130USD | -403USD |
| Unclassified Investing Cash Flow | — | — | — | 3,605,000USD | — | — | — | — |
| Change To Liabilities | — | — | — | — | 1,250,000USD | -2,839,000USD | -1,864,000USD | -5,901,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | 85,500,248USD | 18,728,148USD | 1,313,130USD | 1,031,403USD |
| Net Borrowings | — | — | — | — | — | — | — | -159,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2017Quarterly · 2017-03-31 | Segment | PCT | 7,922,700 | USD | 0000320017-17-000040 |
| Q1 2017Quarterly · 2017-03-31 | Segment | RD | 0 | USD | 0000320017-17-000040 |
| FY 2016Yearly · 2016-12-31 | Segment | PCT | 35,269,800 | USD | 0000320017-17-000008 |
| FY 2016Yearly · 2016-12-31 | Segment | RD | 14,000 | USD | 0000320017-17-000008 |
| Q1 2016Quarterly · 2016-03-31 | Segment | PCT | 7,489,500 | USD | 0000320017-17-000040 |
| Q1 2016Quarterly · 2016-03-31 | Segment | RD | 0 | USD | 0000320017-17-000040 |
| FY 2015Yearly · 2015-12-31 | Segment | PCT | 22,333,100 | USD | 0000320017-17-000008 |
| FY 2015Yearly · 2015-12-31 | Segment | RD | 154,400 | USD | 0000320017-17-000008 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.